Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...
CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...
I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...
Q. I am dealing with a horrible decline from generic Wellbutrin XL. I’ve been on samples of the name brand and my symptoms slowly improved. The generic is definitely a problem. My insurance won’t ...
The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...